Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Acasti Pharma Inc ACST

Acasti Pharma Inc. is a Canada-based late-stage biopharma company with drug candidates addressing rare and orphan diseases. The Company is targeting three underserved orphan diseases: GTX-104, an intravenous infusion targeting subarachnoid hemorrhage (SAH), a rare and life-threatening medical emergency, in which bleeding occurs over the surface of the brain in the subarachnoid space between the... see more

NDAQ:ACST - Post Discussion

Acasti Pharma Inc > Avoid the Boxing Day rush
View:
Post by leblereau on Dec 25, 2020 8:27pm

Avoid the Boxing Day rush

Acasti (ACST) Moves to Buy: Rationale Behind the Upgrade - December 25, 2020 - Zacks.com

L
ooks like this is gonna gap up on Monday in the US and new investors are going to be paying a heavy premium in Canada on Tuesday.

GLTA
Comment by bingostar on Dec 29, 2020 10:27am
Do not trust ZACKS or FOOL , they are full of s , the stock moved because some people moved it , there is no rationale behind the hype , maybe people were inflenced by a disney movie were krill were the stars.
Comment by leblereau on Dec 30, 2020 2:30pm
Acasti is making a nice move today, and its US counterpart is showing convincing volume.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities